HealthSight Diversion Management from BD
As part of the BD HealthSight platform that is designed to support enterprise-wide medication management, the BD HealthSight Diversion Management Analytics application assists with opioid drug diversion investigations by creating an investigation workflow to monitor, triage, and assign potential diversion cases to specific investigators. Compared to statistically based analytical tools that examine opioid amounts dispensed to identify potential diversion, the BD system utilizes machine learning algorithms and multiple dispensing behaviors—such as overrides, canceled transactions, and delays in dispense, administration, or waste—to surface clinicians whose behavior indicates higher risk for diversion.
BD has partnered with Microsoft, which brings expertise in artificial intelligence and data science methodologies, to support development of these machine learning-based algorithms. Importantly, the application also aggregates EMR and dispensing cabinet data to automate what can be a time-consuming manual review process to reconcile and automatically flag anomalous dispense, administration, and waste transactions.
Omnicell Dispensing System Diversion Solutions
Omnicell offers a range of integrated solutions to tighten chain of custody across the controlled substance journey, recognizing that diversion prevention requires vigilance throughout the health care system. In the central pharmacy, the XT Controlled Substance Manager tracks controlled substance inventory from the warehouse to the pharmacy and patient care areas. In operating rooms, the XT Anesthesia Workstation serves as an end-to-end solution that delivers effective oversight in high-diversion areas. To discourage diversion in patient care areas, XT Automated Dispensing Cabinets feature drawers with metal locking lids and an automated single-dose dispenser that eliminates the need for narcotic countbacks. Omnicell’s integration with Epic and Cerner EHRs enables automated reconciliation of controlled substances, with reported monthly time savings of 80% for pharmacy and 74% for nursing.
Bluesight for Controlled Substances from Kit Check
Bluesight for Controlled Substances, a cloud-based software as a service (SaaS) application from Kit Check, provides real-time, comprehensive audit coverage of every controlled substance dose. The system reconciles wholesaler ordering information with inventory stocked in the narcotics vault and the ADC, and what is charted in the patient’s EMR, in both the nursing and perioperative environments. Bluesight allows team members to focus on essential information in an easy-to-use interface, complete with collaboration tools.
The system’s reconciliation engine conducts true, closed-loop dose reconciliation and traces every dispense through the corresponding administrations, waste, and/or return events to ensure that the full volume dispense is accounted for across all documentation systems, care providers, and handoffs. Any variances identified are presented in an easy-to-manage work queue; follow-up steps and escalations can be tracked across departments and users. Bluesight’s machine-learning algorithms analyze large quantities of data across patients, locations, time, movement, and relationships, with the ability to specifically identify outliers within peer groups that do not appear when measuring averages and standard deviations.
RxAuditor Investigate from Medacist Solutions Group
RxAuditor Investigate from Medacist Solutions Group addresses the challenging nature of diversion detection and implements a multidisciplinary approach to reduce overall risk. Streamlining the time-consuming investigation by eliminating manual auditing, the system is powered by Genesis Analytics, an expert system built on a new engine quantified through a knowledge base comprising over 22 years of industry-exclusive automated dispensing system and EMR data from thousands of facilities across the country. This engine powers machine-learning algorithms developed to identify diversion through pattern recognition that has been confirmed by actual diversion events and enriched by multiple other data sources.
This platform delivers a high level of diversion analytics, as hospitals using RxAuditor Investigate have seen dramatic reductions in time spent and costs incurred through drug diversion investigations, and continue to rely on the system to ensure regulatory compliance, reduce liability, and ensure patient safety.
Drug Diversion-Prevention Consulting Services from Visante
Many factors associated with managing a pandemic in hospitals may create new opportunities for drug diversion that could be difficult to detect. Visante uses a unique, multidisciplinary approach to uncover gaps and protect against risk by utilizing expertise from pharmacy operations, informatics, automation, nursing, and clinical services.
Visante’s offerings include a range of diversion-prevention services, including Audit, Program Assessment, Program Development and Implementation, and Corrective and Preventive Action. Audit allows users to validate system performance with an assessment of risk points throughout the chain of custody. It includes a review of all policies, procedures, reports, and documentation related to management of controlled substances. Program Assessment examines the existing program, including review of all policies, procedures, reports, and documentation related to the management of controlled substances, plus an onsite visit to directly observe practices, interview key staff, and identify risk areas throughout the organization. Executive briefings and a final report are also included. Program Development and Implementation offers a customized program to provide a long-term strategy for success, and Corrective and Preventive Action is available for facilities that have experienced a diversion event, identifying root causes and mitigating the risk of future occurrences.
Flowlytics from Invistics
Flowlytics from Invistics uses machine learning and advanced analytics to aggregate data across the hospital system, including EMRs, dispensing cabinets, employee time clocks, wholesale purchasing, and internal inventory. This helps quickly and accurately detect drug diversion and greatly improves the effectiveness and efficiency of the entire process for health care professionals and their staff. Drug diversion protection often only covers patient care, a fraction of the sites from which controlled substances can go missing. A comprehensive drug diversion strategy must include all the points on the complex health system supply chain—from order and initial arrival, to each time the drugs are moved throughout the hospital, administered to patients, and ultimately wasted or returned.
MAAP Analytics from ANiGENT
MAAP Analytics (Medication Administration & Analysis Program) from ANiGENT leverages Mayo Clinic’s intellectual property within a patent-pending platform that collects, normalizes, and analyzes data from multiple sources. The system produces real-time results that pinpoint trends and high-risk events. Built to incorporate individual workflows, it aims to reduce error rates and recoup costs while incorporating knowledge from continuous learning and providing actionable business intelligence.
MAAP Analytics comprises four key modules: Auditor, Waste, Variance, and Performance Analytics. The Auditor module is the operational watch list and action dashboard, while the Waste module provides a portal to reconcile collected waste data utilizing onsite/offsite assay results, which are then integrated into a comprehensive user risk profile. The Variance module normalizes all drugs, locations, and user transactions across multiple ADC and EHR programs, identifying >97% of discrepancies. Performance Analytics provides data analysis and visualization capabilities. Peer-2-Peer (P2P) reporting, a proprietary peer-based comparative analysis, is also available.
WasteLog from Pharmacolog
WasteLog from Pharmacolog is designed to provide a simple and effective way to monitor and safeguard discarded narcotics. The system measures a small sample (0.3 to 0.5 mL) using spectrometry technology to provide a result in 2 to 3 seconds. It is portable, helping users to maximize analyzing the return and waste of injectable controlled substances, compounded IVs, syringes, and PCAs in various areas of the hospital. Broken medication chains can be discovered via a quick test with WasteLog, which will instantly verify a solution’s identity and concentration, thereby ensuring that it has not been tampered with. Key components include onsite calibration of new formulary items, instant analysis and graph results of injectable controlled substances, data that can be shared with hospital analytic software, and the ability to use cuvettes to secure samples for further analysis. Whether the facility is in the planning phase or has a drug diversion-prevention program already in place, WasteLog can easily fit into the hospital workflow.